APO Research
Talk to an analyst

APO RESEARCH · REPORT

GM1 Gangliosidosis Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

GM1 Gangliosidosis Treatment Industry Research Report 2026

19 December 2025112 pages

Choose your research edition.

Industry ResearchGM1 Gangliosidosis Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal GM1 Gangliosidosis Treatment Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal GM1 Gangliosidosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GM1 Gangliosidosis Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal GM1 Gangliosidosis Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global GM1 Gangliosidosis Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for GM1 Gangliosidosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for GM1 Gangliosidosis Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for GM1 Gangliosidosis Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of GM1 Gangliosidosis Treatment include Axovant Gene Therapies Ltd and Passage Bio and Lysogene among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global GM1 Gangliosidosis Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

GM1 Gangliosidosis Treatment Market by Company

Axovant Gene Therapies Ltd

Passage Bio and Lysogene

GM1 Gangliosidosis Treatment Segment by Type

AXO-AAV-GM1

LYS-GM101

PBGM01

GM1 Gangliosidosis Treatment Segment by Application

Type 3 GM1 Gangliosidosis

Type 2 GM1 Gangliosidosis

Type 1 GM1 Gangliosidosis

GM1 Gangliosidosis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GM1 Gangliosidosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GM1 Gangliosidosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GM1 Gangliosidosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of GM1 Gangliosidosis Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of GM1 Gangliosidosis Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of GM1 Gangliosidosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global GM1 Gangliosidosis Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global GM1 Gangliosidosis Treatment Sales (K Units) of Manufacturers (2021-2026) Table 7. Global GM1 Gangliosidosis Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global GM1 Gangliosidosis Treatment Revenue of Manufacturers (2021-2026) Table 9. Global GM1 Gangliosidosis Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market GM1 Gangliosidosis Treatment Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global GM1 Gangliosidosis Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of GM1 Gangliosidosis Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of GM1 Gangliosidosis Treatment, Product Type & Application Table 14. Global GM1 Gangliosidosis Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global GM1 Gangliosidosis Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Axovant Gene Therapies Ltd Company Information Table 19. Axovant Gene Therapies Ltd Business Overview Table 20. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Portfolio Table 22. Axovant Gene Therapies Ltd Recent Developments Table 23. Passage Bio and Lysogene Company Information Table 24. Passage Bio and Lysogene Business Overview Table 25. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Portfolio Table 27. Passage Bio and Lysogene Recent Developments Table 28. Global GM1 Gangliosidosis Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 29. Global GM1 Gangliosidosis Treatment Sales by Region (2021-2026) & (K Units) Table 30. Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2021-2026) Table 31. Global GM1 Gangliosidosis Treatment Sales by Region (2027-2032) & (K Units) Table 32. Global GM1 Gangliosidosis Treatment Sales Market Share by Region (2027-2032) Table 33. Global GM1 Gangliosidosis Treatment Revenue by Region (2021-2026) & (US$ Million) Table 34. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2021-2026) Table 35. Global GM1 Gangliosidosis Treatment Revenue by Region (2027-2032) & (US$ Million) Table 36. Global GM1 Gangliosidosis Treatment Revenue Market Share by Region (2027-2032) Table 37. North America GM1 Gangliosidosis Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. North America GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 39. North America GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 40. North America GM1 Gangliosidosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 41. North America GM1 Gangliosidosis Treatment Revenue by Country (2027-2032) & (US$ Million) Table 42. Europe GM1 Gangliosidosis Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Europe GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 44. Europe GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 45. Europe GM1 Gangliosidosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 46. Europe GM1 Gangliosidosis Treatment Revenue by Country (2027-2032) & (US$ Million) Table 47. Asia Pacific GM1 Gangliosidosis Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Asia Pacific GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 49. Asia Pacific GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 50. Asia Pacific GM1 Gangliosidosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 51. Asia Pacific GM1 Gangliosidosis Treatment Revenue by Country (2027-2032) & (US$ Million) Table 52. South America GM1 Gangliosidosis Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. South America GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 54. South America GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 55. South America GM1 Gangliosidosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 56. South America GM1 Gangliosidosis Treatment Revenue by Country (2027-2032) & (US$ Million) Table 57. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Middle East and Africa GM1 Gangliosidosis Treatment Sales by Country (2021-2026) & (K Units) Table 59. Middle East and Africa GM1 Gangliosidosis Treatment Sales by Country (2027-2032) & (K Units) Table 60. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Country (2021-2026) & (US$ Million) Table 61. Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Country (2027-2032) & (US$ Million) Table 62. Global GM1 Gangliosidosis Treatment Sales by Type (2021-2026) & (K Units) Table 63. Global GM1 Gangliosidosis Treatment Sales by Type (2027-2032) & (K Units) Table 64. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2026) Table 65. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2027-2032) Table 66. Global GM1 Gangliosidosis Treatment Revenue by Type (2021-2026) & (US$ Million) Table 67. Global GM1 Gangliosidosis Treatment Revenue by Type (2027-2032) & (US$ Million) Table 68. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2026) Table 69. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2027-2032) Table 70. Global GM1 Gangliosidosis Treatment Price by Type (2021-2026) & (US$/Unit) Table 71. Global GM1 Gangliosidosis Treatment Price by Type (2027-2032) & (US$/Unit) Table 72. Global GM1 Gangliosidosis Treatment Sales by Application (2021-2026) & (K Units) Table 73. Global GM1 Gangliosidosis Treatment Sales by Application (2027-2032) & (K Units) Table 74. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2026) Table 75. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2027-2032) Table 76. Global GM1 Gangliosidosis Treatment Revenue by Application (2021-2026) & (US$ Million) Table 77. Global GM1 Gangliosidosis Treatment Revenue by Application (2027-2032) & (US$ Million) Table 78. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2026) Table 79. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2027-2032) Table 80. Global GM1 Gangliosidosis Treatment Price by Application (2021-2026) & (US$/Unit) Table 81. Global GM1 Gangliosidosis Treatment Price by Application (2027-2032) & (US$/Unit) Table 82. Key Raw Materials Table 83. Raw Materials Key Suppliers Table 84. GM1 Gangliosidosis Treatment Distributors List Table 85. GM1 Gangliosidosis Treatment Customers List Table 86. GM1 Gangliosidosis Treatment Industry Trends Table 87. GM1 Gangliosidosis Treatment Industry Drivers Table 88. GM1 Gangliosidosis Treatment Industry Restraints Table 89. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. GM1 Gangliosidosis Treatment Product Image Figure 5. Global GM1 Gangliosidosis Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global GM1 Gangliosidosis Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global GM1 Gangliosidosis Treatment Sales (2021-2032) & (K Units) Figure 8. Global GM1 Gangliosidosis Treatment Average Price (US$/Unit) & (2021-2032) Figure 9. AXO-AAV-GM1 Product Image Figure 10. LYS-GM101 Product Image Figure 11. PBGM01 Product Image Figure 12. Type 3 GM1 Gangliosidosis Product Image Figure 13. Type 2 GM1 Gangliosidosis Product Image Figure 14. Type 1 GM1 Gangliosidosis Product Image Figure 15. Global GM1 Gangliosidosis Treatment Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of GM1 Gangliosidosis Treatment, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 GM1 Gangliosidosis Treatment Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global GM1 Gangliosidosis Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global GM1 Gangliosidosis Treatment Sales by Region in 2025 Figure 21. Global GM1 Gangliosidosis Treatment Revenue by Region in 2025 Figure 22. North America GM1 Gangliosidosis Treatment Market Size by Country in 2025 Figure 23. North America GM1 Gangliosidosis Treatment Sales Market Share by Country (2021-2032) Figure 24. North America GM1 Gangliosidosis Treatment Revenue Market Share by Country (2021-2032) Figure 25. United States GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe GM1 Gangliosidosis Treatment Market Size by Country in 2025 Figure 28. Europe GM1 Gangliosidosis Treatment Sales Market Share by Country (2021-2032) Figure 29. Europe GM1 Gangliosidosis Treatment Revenue Market Share by Country (2021-2032) Figure 30. Germany GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific GM1 Gangliosidosis Treatment Market Size by Country in 2025 Figure 36. Asia Pacific GM1 Gangliosidosis Treatment Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific GM1 Gangliosidosis Treatment Revenue Market Share by Country (2021-2032) Figure 38. China GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America GM1 Gangliosidosis Treatment Market Size by Country in 2025 Figure 47. South America GM1 Gangliosidosis Treatment Sales Market Share by Country (2021-2032) Figure 48. South America GM1 Gangliosidosis Treatment Revenue Market Share by Country (2021-2032) Figure 49. Mexico GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa GM1 Gangliosidosis Treatment Market Size by Country in 2025 Figure 53. Middle East and Africa GM1 Gangliosidosis Treatment Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa GM1 Gangliosidosis Treatment Revenue Market Share by Country (2021-2032) Figure 55. Turkey GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE GM1 Gangliosidosis Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2032) Figure 59. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2032) Figure 60. Global GM1 Gangliosidosis Treatment Price (US$/Unit) by Type (2021-2032) Figure 61. Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2032) Figure 62. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2032) Figure 63. Global GM1 Gangliosidosis Treatment Price (US$/Unit) by Application (2021-2032) Figure 64. GM1 Gangliosidosis Treatment Value Chain Figure 65. GM1 Gangliosidosis Treatment Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. GM1 Gangliosidosis Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • AXO-AAV-GM1
  • LYS-GM101
  • PBGM01
Applications
  • Type 3 GM1 Gangliosidosis
  • Type 2 GM1 Gangliosidosis
  • Type 1 GM1 Gangliosidosis
Companies covered
  • Axovant Gene Therapies Ltd
  • Passage Bio and Lysogene

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global GM1 Gangliosidosis Treatment Market Size (2021-2032)
  4. 2.2.2 Global GM1 Gangliosidosis Treatment Sales (2021-2032)
  5. 2.2.3 Global GM1 Gangliosidosis Treatment Market Average Price (2021-2032)
  6. 2.3 GM1 Gangliosidosis Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 AXO-AAV-GM1
  9. 2.3.3 LYS-GM101
  10. 2.3.4 PBGM01
  11. 2.4 GM1 Gangliosidosis Treatment by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Type 3 GM1 Gangliosidosis
  14. 2.4.3 Type 2 GM1 Gangliosidosis
  15. 2.4.4 Type 1 GM1 Gangliosidosis
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global GM1 Gangliosidosis Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global GM1 Gangliosidosis Treatment Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global GM1 Gangliosidosis Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global GM1 Gangliosidosis Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global GM1 Gangliosidosis Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of GM1 Gangliosidosis Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of GM1 Gangliosidosis Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of GM1 Gangliosidosis Treatment, Established Date
  9. 3.9 Global GM1 Gangliosidosis Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Axovant Gene Therapies Ltd
  2. 4.1.1 Axovant Gene Therapies Ltd Company Information
  3. 4.1.2 Axovant Gene Therapies Ltd Business Overview
  4. 4.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Portfolio
  6. 4.1.5 Axovant Gene Therapies Ltd Recent Developments
  7. 4.2 Passage Bio and Lysogene
  8. 4.2.1 Passage Bio and Lysogene Company Information
  9. 4.2.2 Passage Bio and Lysogene Business Overview
  10. 4.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Portfolio
  12. 4.2.5 Passage Bio and Lysogene Recent Developments
5 Global GM1 Gangliosidosis Treatment Market Scenario by Region
  1. 5.1 Global GM1 Gangliosidosis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global GM1 Gangliosidosis Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global GM1 Gangliosidosis Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global GM1 Gangliosidosis Treatment Sales by Region: 2027-2032
  5. 5.3 Global GM1 Gangliosidosis Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global GM1 Gangliosidosis Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global GM1 Gangliosidosis Treatment Revenue by Region: 2027-2032
  8. 5.4 North America GM1 Gangliosidosis Treatment Market Facts & Figures by Country
  9. 5.4.1 North America GM1 Gangliosidosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America GM1 Gangliosidosis Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America GM1 Gangliosidosis Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe GM1 Gangliosidosis Treatment Market Facts & Figures by Country
  15. 5.5.1 Europe GM1 Gangliosidosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe GM1 Gangliosidosis Treatment Sales by Country (2021-2032)
  17. 5.5.3 Europe GM1 Gangliosidosis Treatment Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific GM1 Gangliosidosis Treatment Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific GM1 Gangliosidosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific GM1 Gangliosidosis Treatment Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific GM1 Gangliosidosis Treatment Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America GM1 Gangliosidosis Treatment Market Facts & Figures by Country
  35. 5.7.1 South America GM1 Gangliosidosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America GM1 Gangliosidosis Treatment Sales by Country (2021-2032)
  37. 5.7.3 South America GM1 Gangliosidosis Treatment Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa GM1 Gangliosidosis Treatment Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa GM1 Gangliosidosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa GM1 Gangliosidosis Treatment Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa GM1 Gangliosidosis Treatment Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global GM1 Gangliosidosis Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global GM1 Gangliosidosis Treatment Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global GM1 Gangliosidosis Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global GM1 Gangliosidosis Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global GM1 Gangliosidosis Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global GM1 Gangliosidosis Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global GM1 Gangliosidosis Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global GM1 Gangliosidosis Treatment Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global GM1 Gangliosidosis Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global GM1 Gangliosidosis Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global GM1 Gangliosidosis Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global GM1 Gangliosidosis Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 GM1 Gangliosidosis Treatment Value Chain Analysis
  2. 8.1.1 GM1 Gangliosidosis Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 GM1 Gangliosidosis Treatment Production Mode & Process
  5. 8.2 GM1 Gangliosidosis Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 GM1 Gangliosidosis Treatment Distributors
  8. 8.2.3 GM1 Gangliosidosis Treatment Customers
9 Global GM1 Gangliosidosis Treatment Analyzing Market Dynamics
  1. 9.1 GM1 Gangliosidosis Treatment Industry Trends
  2. 9.2 GM1 Gangliosidosis Treatment Industry Drivers
  3. 9.3 GM1 Gangliosidosis Treatment Industry Opportunities and Challenges
  4. 9.4 GM1 Gangliosidosis Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst